About: Radretumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Radretumab is an antineoplastic. , a pharmaceutical company specializing in antibody-drug conjugates, is developing it as a conjugate of Iodine-131 to an antibody which binds to fibronectin extra domain-B for treatment of Hodgkin lymphoma.

Property Value
dbo:abstract
  • Radretumab is an antineoplastic. , a pharmaceutical company specializing in antibody-drug conjugates, is developing it as a conjugate of Iodine-131 to an antibody which binds to fibronectin extra domain-B for treatment of Hodgkin lymphoma. (en)
dbo:casNumber
  • 1253180-81-2
dbo:fdaUniiCode
  • 6JVA140UB4
dbo:wikiPageID
  • 33051846 (xsd:integer)
dbo:wikiPageLength
  • 3033 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1031107868 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:casNumber
  • 1253180 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:mabType
  • mab (en)
dbp:source
  • u (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • 6 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 464379793 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Radretumab is an antineoplastic. , a pharmaceutical company specializing in antibody-drug conjugates, is developing it as a conjugate of Iodine-131 to an antibody which binds to fibronectin extra domain-B for treatment of Hodgkin lymphoma. (en)
rdfs:label
  • Radretumab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License